Naoyuki Katayama

Naoyuki Katayama

Auto-generated profile, based on publicly available information

Naoyuki Katayama

Department of Hematology and Oncology, Mie University Graduate School of Medicine, Tsu, Japan

Research Focus & Metrics

Academic Career Length

37Years (1990-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 July 2018 in Thrombosis Journal
Verified
Journal Article
Open access
PDF file
Hideo WadaHideo Wada
Hideo Wada
TMTakeshi Mastumoto
Takeshi Mastumoto
KSKei Suzuki
Kei Suzuki
HIHiroshi Imai
Hiroshi Imai
NKNaoyuki Katayama
Naoyuki Katayama
MMMasanori Matsumoto
Masanori Matsumoto
Both disseminated intravascular coagulation (DIC) and thrombotic microangiopathy (TMA) cause microvascular thrombosis associated with thrombocytopenia, bleeding tendency and organ failure. The frequency of DIC is higher than that of thrombotic thrombocytopenic purpura (TTP). Many patients with TMA are diagnosed with DIC, but only about 15% of DIC patients are diagnosed with TMA. Hyperfibrinolysis is observed in most patients with DIC, and microangiopathic hemolytic anemia is observed in most patients with TMA. Markedly decreased ADAMTS13 activity, the presence of Shiga-toxin-producing Escherichia coli (STEC) and abnormality of the complement system are useful for the diagnosis of TTP, STEC-hemolytic uremic syndrome (HUS)and atypical HUS, respectively. However, there are no specific biomarkers for the diagnosis of DIC. Although DIC and TMA are similar appearances, all coagulation, fibrinolysis and platelet systems are activated in DIC, and only platelets are markedly activated in TMA.

21 July 2005 in Journal of Leukocyte Biology
Verified
Journal Article
Open access
PDF file
NHNatsuki Hoshino
Natsuki Hoshino
NKNaoyuki Katayama
Naoyuki Katayama
TSTetsunori Shibasaki
Tetsunori Shibasaki
KOKohshi Ohishi
Kohshi Ohishi
JNJunji Nishioka
Junji Nishioka
HSHiroshi Shiku
Hiroshi Shiku
Human Langerhans cells (LCs) are of hematopoietic origin, but cytokine regulation of their development is not fully understood. Notch ligand Delta-1 is expressed in a proportion of the skin. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and transforming growth factor-β1 (TGF-β1) are also secreted in the skin. We report here that Delta-1, in concert with GM-CSF and TGF-β1, induces the differentiation of human CD14+ blood monocytes into cells that express LC markers: CD1a, Langerin, cutaneous lymphocyte-associated antigen, CC chemokine receptor 6, E-cadherin, and Birbeck granules. The resulting cells display phagocytic activity and chemotaxis to macrophage inflammatory protein-1α (MIP-1α). In response to CD40 ligand and tumor necrosis factor α, the cells acquire a mature phenotype of dendritic cells that is characterized by up-regulation of human leukocyte antigen (HLA)-ABC, HLA-DR, CD80, CD86, CD40, and CD54 and appearance of CD83. These cells in turn show chemotaxis toward MIP-1β and elicit activation of CD8+ T cells and T helper cell type 1 polarization of CD4+ T cells. Thus, blood monocytes can give rise to LCs upon exposure to the skin cytokine environment consisting of Delta-1, GM-CSF, and TGF-β1, which may be, in part, relevant to the development of human epidermal LCs. Our results extend the functional scope of Notch ligand δ-1 in human hematopoiesis.

1 April 2002 in International Journal of Hematology
Verified
Journal Article
Closed access
PDF file
MMMasahiro Masuya
Masahiro Masuya
NKNaoyuki Katayama
Naoyuki Katayama
NHNatsuki Hoshino
Natsuki Hoshino
HNHiroyoshi Nishikawa
Hiroyoshi Nishikawa
SSSeiji Sakano
Seiji Sakano
HSHiroshi Shiku
Hiroshi Shiku

8 January 2014 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KIKazuko Ino
Kazuko Ino
MMMasahiro Masuya
Masahiro Masuya
ITIsao Tawara
Isao Tawara
EMEri Miyata
Eri Miyata
KOKeiko Oda
Keiko Oda
NKNaoyuki Katayama
Naoyuki Katayama
Recent studies have shown that monocytes possess pluripotent plasticity. We previously reported that monocytes could differentiate into hepatic stellate cells. Although stellate cells are also present in the pancreas, their origin remains unclear. An accumulation of enhanced green fluorescent protein (EGFP)+CD45– cells was observed in the pancreases and livers of chimeric mice, which were transplanted with a single hematopoietic stem cell isolated from EGFP-transgenic mice and treated with carbon tetrachloride (CCl4). Because the vast majority of EGFP+CD45– cells in the pancreas expressed stellate cell-associated antigens such as vimentin, desmin, glial fibrillary acidic protein, procollagen-I, and α-smooth muscle actin, they were characterized as pancreatic stellate cells (PaSCs). EGFP+ PaSCs were also observed in CCl4-treated mice adoptively transferred with monocytes but not with other cell lineages isolated from EGFP-transgenic mice. The expression of monocyte chemoattractant protein-1 (MCP-1) and angiotensin II (Ang II) increased in the pancreas of CCl4-treated mice and their respective receptors, C-C chemokine receptor 2 (CCR2) and Ang II type 1 receptor (AT1R), were expressed on Ly6Chigh monocytes isolated from EGFP-transgenic mice. We examined the effect of an AT1R antagonist, irbesartan, which is also a CCR2 antagonist, on the migration of monocytes into the pancreas. Monocytes migrated toward MCP-1 but not Ang II in vitro. Irbesartan inhibited not only their in vitro chemotaxis but also in vivo migration of adoptively transferred monocytes from peripheral blood into the pancreas. Irbesartan treatment significantly reduced the numbers of EGFP+F4/80+CCR2+ monocytic cells and EGFP+ PaSCs in the pancreas of CCl4-treated chimeric mice receiving EGFP+ bone marrow cells. A specific CCR2 antagonist RS504393 inhibited the occurrence of EGFP+ PaSCs in injured mice. We propose that CCR2+ monocytes migrate into the pancreas possibly via the MCP-1/CCR2 pathway and give rise to PaSCs.

30 March 2012 in British Journal of Haematology
Verified
Journal Article
Open access
PDF file
YNYoshiki Nakamori
Yoshiki Nakamori
BLBing Liu
Bing Liu
KOKohshi Ohishi
Kohshi Ohishi
KSKei Suzuki
Kei Suzuki
KIKazuko Ino
Kazuko Ino
NKNaoyuki Katayama
Naoyuki Katayama
Summary: The regulation of human early lymphopoiesis remains unclear. B‐ and T‐lineage cells cannot develop simultaneously with conventional stromal cultures. Here we show that telomerized human bone marrow stromal cells supported simultaneous generation of CD19+CD34lo/−CD10+cyCD79a+CD20+/−VpreB− pro‐B cells and CD7+CD34+ CD45RA+CD56−cyCD3− early T/Natural Killer (NK) cell precursors from human haematopoietic progenitors, and the generation of both lymphoid precursors was promoted by flt3 ligand (flt3L). On the other hand, stem cell factor or thrombopoietin had little or no effect when used alone. However, both acted synergistically with flt3L to augment the generation of both lymphoid precursors. Characteristics of these lymphoid precursors were evaluated by gene expression profiles, rearrangements of IgH genes, or replating assays. Similar findings were observed with primary human bone marrow stromal cells. Notably, these two lymphoid‐lineage precursors were generated without direct contact with stromal cells, indicating that early B and T/NK development can occur, at least in part, by stromal cell‐derived humoral factors. In serum‐free cultures, flt3L elicited similar effects and appeared particularly important for B cell development. The findings of this study identified the potential of human bone marrow stromal cells to support human early B and T lymphopoiesis and a principal role for flt3L during early lymphopoiesis.

1 October 2015 in Cancer Genetics
Verified
Journal Article
Closed access
YSYuka Sugimoto
Yuka Sugimoto
ASAkiko Sada
Akiko Sada
YSYuji Shimokariya
Yuji Shimokariya
FMFumihiko Monma
Fumihiko Monma
KOKohshi Ohishi
Kohshi Ohishi
NKNaoyuki Katayama
Naoyuki Katayama